Anzeige
Meldung des Tages: Golden Cross bestätigt ein Fosterville-ähnliches System — und jetzt wird tiefer gebohrt

DBV Technologies News

Aktie
WKN:  A1JWB7 ISIN:  FR0010417345 US-Symbol:  DBVTF Branche:  Biotechnologie Land:  Frankreich
3,645 €
-0,105 €
-2,80%
02.04.26
Depot/Watchlist
Marktkapitalisierung *
436,97 Mio. €
Streubesitz
32,19%
KGV
-0,53
Index-Zuordnung
-

DBV Technologies News

02.04.26 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of March 31, 2026 (Article 223-16 of the General Regulations of the ...
26.03.26 - GlobeNewswire
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
Châtillon, France, March 26, 2026 DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext ...
26.03.26 - GlobeNewswire
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
Châtillon, France, March 26, 2026 DBV Technologies Reports Full Year 2025 Financial Results and Business Update Continued advancing the VIASKIN® Peanut Patch clinical ...
24.03.26 - GlobeNewswire
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Châtillon, France, March 24, 2026 DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Changes went into effect on Monday, March ...
04.03.26 - GlobeNewswire
DBV Technologies to Participate in Upcoming March Investor Conferences
Châtillon, France, March 4, 2026 DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock ...
03.03.26 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of February 28, 2026 (Article 223-16 of the General Regulations of the ...
28.02.26 - GlobeNewswire
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting Approximately 83% of ...
10.02.26 - GlobeNewswire
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
Châtillon, France, February 10, 2026 DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and ...
09.02.26 - GlobeNewswire
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
Châtillon, France, February 9, 2025 DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit DBV Technologies (Euronext: DBV – ISIN ...
05.02.26 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of January 31, 2026 (Article 223-16 of the General Regulations of the ...
17.01.26 - GlobeNewswire
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its ...
12.01.26 - GlobeNewswire
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total number of Voting Rights and  Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the ...
07.01.26 - GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated Information Châtillon, France, January 7, 2026 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN ...
05.01.26 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the ...
16.12.25 - GlobeNewswire
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Châtillon, France, December 16, 2025 DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children ...
02.12.25 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of November 30, 2025 (Article 223-16 of the General Regulations of the ...
12.11.25 - GlobeNewswire
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Châtillon, France, November 11, 2025 DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN ® Peanut Patch in Peanut Allergic ...
04.11.25 - GlobeNewswire
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Châtillon, France, November 4, 2025 DBV Technologies to Participate in the Guggenheim 2 nd Annual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN ...
03.11.25 - GlobeNewswire
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
Chatillion, France, November 3, 2025 DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer DBV Technologies (Euronext: DBV – ISIN ...
03.11.25 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of October 31, 2025 (Article 223-16 of the General Regulations of the ...

Newssuche

Videos

newspaper
03.04.26
RW QUANTUM Strategie Einführung
Am Sonntag, den 12.4.26 wird erstmals die RW QUANTUM Strategie geschult. Der Ansatz handelt die ... Mehr »